Back

BET protein inhibition rewires the vascular-fat interface in cardiometabolic disease

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Metabolic reprogramming and crosstalk in cardiometabolic and vascular disease Lipid Metabolism, Metabolic Syndrome, Diabetes ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Assistant Professor Alessandro Mengozzi

University of Pisa, Pisa (Italy)

4 More presentations in this session

Presentation thumbnail
Liraglutide attenuates high glucose-induced 'trained immunity' in cd34+ hematopoietic stem cells
Doctor G. Damiano (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Targeting Perilipin 2 alleviates vascular aging through regulation of lipid droplet-mitochondria tethering and fatty acid oxidation
Doctor T. Lu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Heterozygous loss-of-function mutation in TBX5 causes dysregulation of energy metabolism, mitochondrial metabolic pathways and cholesterol metabolism disturbing cardiomyocyte cell physiology
Doctor M. Dressen (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Epicardial adipose tissue-derived kynurenic acid induces atrial lymphatic dysfunction in atrial fibrillation.
Doctor M. Takahashi (Oita, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Metabolic reprogramming and crosstalk in cardiometabolic and vascular disease
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Targeting BRD4-HK2 reverses the meta-inflammatory shift in perivascular adipose tissue and rescues cardiometabolic vascular dysfunction.
thumbnail
Congress Session
Metabolic reprogramming and crosstalk in cardiometabolic and vascular disease
thumbnail
Congress Session
Epigenetic targets in cardiovascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources